Celltrion reported KRW7.53B in Interest Income for its fiscal quarter ending in March of 2025.


Interest Income Change Date
Celltrion KRW 7.53B 1.21B Mar/2025
Dianthus Therapeutics USD 3.4M 587K Jun/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
IQVIA Holdings USD 10M 1000K Jun/2025
Moderna USD 81M 9M Jun/2025
Revvity USD 10.08M 253K Mar/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Xeris Pharmaceuticals USD 948K 38K Jun/2025